학술논문

Preclinical activity of glypican-3 (GPC3) and NKp46 directed FLEX-NKT engager antibody (CYT-303) in combination with iPSC derived natural killer cells (iNKs) or peripheral blood (PB) NK cells in hepatocellular carcinoma (HCC)
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; SEP 1 2022, 28 17, 2p. Supplement: S
Subject
Language
English
ISSN
15573265